Investors are growing more optimistic over the company's pipeline and the initiation of a Phase 1 trial with a new drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results